Active, Not Recruiting
Programmed Death-1 (PD-1) Antibody Combined With Chemoradiotherapy in High-risk Recurrent Nasopharyngeal Carcinoma
NCT03930498
- Conditions
- Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +12 more
- Locations
-
- Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China